These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


458 related items for PubMed ID: 8823321

  • 21. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
    Salloum E, Doria R, Farber LR, Roberts KB, Cooper DL.
    Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
    [Abstract] [Full Text] [Related]

  • 22. Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study.
    Cimino G, Papa G, Tura S, Mazza P, Rossi Ferrini PL, Bosi A, Amadori S, Lo Coco F, D'Arcangelo E, Giannarelli D.
    J Clin Oncol; 1991 Mar; 9(3):432-7. PubMed ID: 1999712
    [Abstract] [Full Text] [Related]

  • 23. Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.
    Koletsky AJ, Bertino JR, Farber LR, Prosnitz LR, Kapp DS, Fischer D, Portlock CS.
    J Clin Oncol; 1986 Mar; 4(3):311-7. PubMed ID: 3950674
    [Abstract] [Full Text] [Related]

  • 24. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
    Marcus KC, Kalish LA, Coleman CN, Shulman LN, Rosenthal DS, Canellos GP, Mauch PM.
    J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
    [Abstract] [Full Text] [Related]

  • 25. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
    Schaapveld M, Aleman BM, van Eggermond AM, Janus CP, Krol AD, van der Maazen RW, Roesink J, Raemaekers JM, de Boer JP, Zijlstra JM, van Imhoff GW, Petersen EJ, Poortmans PM, Beijert M, Lybeert ML, Mulder I, Visser O, Louwman MW, Krul IM, Lugtenburg PJ, van Leeuwen FE.
    N Engl J Med; 2015 Dec 24; 373(26):2499-511. PubMed ID: 26699166
    [Abstract] [Full Text] [Related]

  • 26. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease.
    Beaty O, Hudson MM, Greenwald C, Luo X, Fang L, Wilimas JA, Thompson EI, Kun LE, Pratt CB.
    J Clin Oncol; 1995 Mar 24; 13(3):603-9. PubMed ID: 7884422
    [Abstract] [Full Text] [Related]

  • 27. High risk of breast carcinoma after irradiation of young women with Hodgkin's disease.
    Aisenberg AC, Finkelstein DM, Doppke KP, Koerner FC, Boivin JF, Willett CG.
    Cancer; 1997 Mar 15; 79(6):1203-10. PubMed ID: 9070499
    [Abstract] [Full Text] [Related]

  • 28. Late complications of therapy of Hodgkin's disease: prevention and management.
    Ng AK, Mauch PM.
    Curr Hematol Rep; 2004 Jan 15; 3(1):27-33. PubMed ID: 14695846
    [Abstract] [Full Text] [Related]

  • 29. Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report.
    Bartlett NL, Rosenberg SA, Hoppe RT, Hancock SL, Horning SJ.
    J Clin Oncol; 1995 May 15; 13(5):1080-8. PubMed ID: 7537796
    [Abstract] [Full Text] [Related]

  • 30. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
    Mauch PM, Kalish LA, Marcus KC, Shulman LN, Krill E, Tarbell NJ, Silver B, Weinstein H, Come S, Canellos GP, Coleman CN.
    Cancer J Sci Am; 1995 May 15; 1(1):33-42. PubMed ID: 9166452
    [Abstract] [Full Text] [Related]

  • 31. Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age.
    Abrahamsen JF, Andersen A, Hannisdal E, Nome O, Abrahamsen AF, Kvaløy S, Høst H.
    J Clin Oncol; 1993 Feb 15; 11(2):255-61. PubMed ID: 8426202
    [Abstract] [Full Text] [Related]

  • 32. Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma.
    Travis LB, Weeks J, Curtis RE, Chaffey JT, Stovall M, Banks PM, Boice JD.
    J Clin Oncol; 1996 Feb 15; 14(2):565-71. PubMed ID: 8636772
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease.
    Hancock SL, Tucker MA, Hoppe RT.
    JAMA; 1993 Oct 27; 270(16):1949-55. PubMed ID: 8411552
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
    Haberer S, Belin L, Le Scodan R, Kirova YM, Savignoni A, Stevens D, Moisson P, Decaudin D, Pierga JY, Reyal F, Campana F, Fourquet A, Bollet MA.
    Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):e145-52. PubMed ID: 21605948
    [Abstract] [Full Text] [Related]

  • 37. Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement.
    Hughes-Davies L, Tarbell NJ, Coleman CN, Silver B, Shulman LN, Linggood R, Canellos GP, Mauch PM.
    Int J Radiat Oncol Biol Phys; 1997 Sep 01; 39(2):361-9. PubMed ID: 9308940
    [Abstract] [Full Text] [Related]

  • 38. Cardiac disease following treatment of Hodgkin's disease in children and adolescents.
    Hancock SL, Donaldson SS, Hoppe RT.
    J Clin Oncol; 1993 Jul 01; 11(7):1208-15. PubMed ID: 8315419
    [Abstract] [Full Text] [Related]

  • 39. Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radio-therapy: analysis of efficacy and long-term toxicity.
    Brusamolino E, Lunghi F, Orlandi E, Astori C, Passamonti F, Baraté C, Pagnucco G, Baio A, Franchini P, Lazzarino M, Bernasconi C.
    Haematologica; 2000 Oct 01; 85(10):1032-9. PubMed ID: 11025593
    [Abstract] [Full Text] [Related]

  • 40. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM, Anselmo AP, Donato V, Falchetto Osti M, Santoro M, Tombolini V, Mandelli F.
    Haematologica; 1999 Oct 01; 84(10):917-23. PubMed ID: 10509040
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 23.